Prolonged persistence of SARS-CoV-2 infection during A+AVD therapy for classical Hodgkin's lymphoma: A case report
- 1 December 2021
- journal article
- research article
- Published by Elsevier in Current Problems in Cancer
- Vol. 45 (6) , 100739
Abstract
No abstract availableKeywords
This publication has 14 references indexed in Scilit:
- High levels of anti-SSA/Ro antibodies in COVID-19 patients with severe respiratory failure: a case-based reviewClinical Rheumatology, 2020
- Duration of infectiousness and correlation with RT-PCR cycle threshold values in cases of COVID-19, England, January to May 2020Eurosurveillance, 2020
- Poor outcome and prolonged persistence of SARS‐CoV‐2 RNA in COVID‐19 patients with haematological malignancies; King's College Hospital experienceBritish Journal of Haematology, 2020
- Determinants of COVID-19 disease severity in patients with cancerNature Medicine, 2020
- COVID-19 mortality in patients with cancer on chemotherapy or other anticancer treatments: a prospective cohort studyThe Lancet, 2020
- Persisting SARS‐CoV‐2 viraemia after rituximab therapy: two cases with fatal outcome and a review of the literatureBritish Journal of Haematology, 2020
- Predicting Infectious Severe Acute Respiratory Syndrome Coronavirus 2 From Diagnostic SamplesClinical Infectious Diseases, 2020
- Comorbidity and its impact on 1590 patients with COVID-19 in China: a nationwide analysisEuropean Respiratory Journal, 2020
- Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort studyThe Lancet, 2020
- Molecular Diagnosis of a Novel Coronavirus (2019-nCoV) Causing an Outbreak of PneumoniaClinical Chemistry, 2020